The ERS Congress 2025

ERS: Insights to help improve the lives of patients with AATD

Visit the Grifols booth at the ERS Congress to learn more. If you can’t wait, download the full study below.

Want early access to the study?

Download a multinational study on AAT augmentation therapy. This research demonstrates the significant¹ survival benefits of intravenous alpha-₁antitrypsin (AAT) augmentation therapy for patients with alpha-₁antitrypsin deficiency (AATD), a condition that leads to progressive lung damage. By attending our symposium at the ERS Congress, you’ll gain insights into these findings and learn how they can shape your approach to care.

Download the study now

Fill out the form below and instantly receive the full study on AAT augmentation therapy and its impact on survival.

Speak to us at the ERS Congress

Visit our booth at the ERS Congress - Join us in Amsterdam from 27 September ➞ 1 October

WATCH

Insights on AAT Augmentation Therapy & Survival

Explore the key findings from the multinational study on the benefits of intravenous AAT augmentation therapy in improving survival and lung function for patients with AATD.

Get the Full Study Delivered to Your Inbox

Fill out the form below to download the complete study on AAT augmentation therapy. We look forward to seeing you at the ERS Congress in September.

All fields are required unless otherwise stated

First Name

Last Name

Email Address

Healthcare Institution

Country

Specialty

Position

Data Protection Information
The Grifols' group company to which you submit the request, as data controller, will process your personal data to provide information about our products. The legal basis is your consent. Your data may be shared with Grifols' group companies and other third parties. You have the right to access, rectify and erase, as well as any other rights detailed in the additional information. For additional information on personal data protection check here.

recaptcha-check Required

By clicking the button below, I agree that my data will be used as described in this form.

References

Fraughen DD, Ghosh AJ, Hobbs BD, et al. Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival and is decoupled from spirometric decline-A multinational registry analysis. Am J Respir Crit Care Med. 2023;208(9):964-974.